Pneumococcal conjugate second or third-dose vaccines (PCVc) in Sierra Leone
Sierra Leone: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 93.0% in 2025. ▲ Rising
Latest (2025)
93.0%
Change on year
unchanged
World rank
53rd
of 194 countries
All-time high
94.0%
in 2019
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Sierra Leone, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Sierra Leone stood at 93.0%.
The figure is up 8.1% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Sierra Leone peaked at 94.0% in 2019 and was at its lowest, 0.0%, in 2008.
Sierra Leone ranks 53rd of 194 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Sierra Leone, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 75.0% | — |
| 2012 | 92.0% | +22.7% |
| 2013 | 92.0% | +0.0% |
| 2014 | 83.0% | -9.8% |
| 2015 | 86.0% | +3.6% |
| 2016 | 84.0% | -2.3% |
| 2017 | 90.0% | +7.1% |
| 2018 | 92.0% | +2.2% |
| 2019 | 94.0% | +2.2% |
| 2020 | 91.0% | -3.2% |
| 2021 | 90.0% | -1.1% |
| 2022 | 93.0% | +3.3% |
| 2023 | 93.0% | +0.0% |
| 2024 | 93.0% | +0.0% |
| 2025 | 93.0% | +0.0% |
Sierra Leone compared with similar countries
- Sierra Leone's 93.0% is above the median for low income countries, which is 80.0%, 1.2× the median. (25 countries reporting)
- Sierra Leone's 93.0% is above the median for Sub-Saharan Africa, which is 82.5%, 1.1× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 78.8% | 0.0% | 94.0% | 10 |
| 2020s | 92.2% | 90.0% | 93.0% | 6 |
Countries ranked near Sierra Leone
More health data for Sierra Leone
- Un projection of annual infant deaths, annual growth rate -2.34 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.773 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,199 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,209 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 38 (2025)
- Population ages 00-04, female, annual growth rate 0.6447 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0663 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.6611 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Sierra Leone?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Sierra Leone was 93.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Sierra Leone?
- The highest recorded value was 94.0% in 2019.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Sierra Leone?
- The lowest recorded value was 0.0% in 2008.
- How does Sierra Leone rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Sierra Leone ranks 53rd out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Sierra Leone?
- Over the last ten years it is up 8.1%. The long-run trend across the full record is rising.
- Where does this Sierra Leone data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).